Aller au contenu
RécupérationArticle de recherche3 min read

Lower HRV tracks with sleep apnea and COPD severity, and is lowest when both occur

Collectif éditorial MoveVitals · Study published · Reading updated

Original paper:Heart Rate Variability (HRV) in Patients with Sleep Apnea and COPD: A Comprehensive Analysis. · Journal of clinical medicine · 2025 · Article original ↗

À retenir

A review of 41 studies (from 239 identified) found consistent evidence linking reduced heart rate variability with the severity of obstructive sleep apnea (OSA) and COPD, and more pronounced changes in overlap syndrome. The authors' view that HRV is a valuable clinical tool goes beyond what a narrative literature review can prove.

Study design

Article de recherche

Reading basis

Published abstract

Reading focus

Design & applicability

Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.

Question de recherche

OSA and chronic obstructive pulmonary disease (COPD) are common, overlapping conditions that both affect the autonomic nervous system. The authors reviewed whether heart rate variability (HRV) could help with diagnosis, prognosis and treatment monitoring in these patients.

Population et méthode

Literature review using PubMed, Google Scholar and MEDLINE for peer-reviewed English-language studies from January 2015 to December 2024 that evaluated HRV in people with OSA, COPD or overlap syndrome, or explored HRV as a marker of severity or progression. Of 239 studies identified, 41 met the inclusion criteria. Results were summarised narratively; the abstract does not report pooled numbers or quality ratings.

Résultats

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    Reduced HRV was consistently linked with both OSA and COPD severity.
  2. 2
    HRV changes were more pronounced in overlap syndrome, which the authors describe as synergistic autonomic dysfunction.
  3. 3
    HRV showed potential to separate disease stages, predict cardiovascular risk and evaluate treatment, particularly CPAP therapy in OSA.
  4. 4
    Short-term HRV was particularly sensitive to autonomic changes, while long-term recordings helped track progression.
  5. 5
    Emerging evidence supports HRV from wearable technology as a viable screening tool for health and wellness.

Limites et incertitude

  1. 1
    It is a narrative review without reported effect sizes, so how large or reliable the links are cannot be judged.
  2. 2
    Associations between HRV and severity do not show that HRV can diagnose or predict outcomes for an individual.
  3. 3
    The authors themselves say longitudinal studies are needed to standardise HRV thresholds and validate routine screening use.
  4. 4
    This reading is based on the abstract only.

Mise en perspective

Lower HRV goes along with more severe sleep apnea and COPD, but low HRV alone is not a diagnosis, since many other things lower it. Loud snoring, daytime sleepiness or breathlessness should be assessed by a clinician, and treatment such as CPAP is a medical decision.

Vos données

A wearable's nightly HRV can be compared with your own baseline across weeks, using the same device and similar bedtimes. A persistent drop with poor sleep or breathing symptoms is worth raising with a clinician, but it cannot confirm apnea or COPD.

Comprendre ce type de preuve

The index does not establish a precise design. Read the methods before making causal claims; check population, comparator, outcomes and uncertainty in the source.

Résumé structuré des auteurs English

Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.

Background

Obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD) are prevalent conditions with overlapping clinical features and shared consequences on autonomic function. Heart rate variability (HRV), a non-invasive biomarker of autonomic nervous system activity, may offer diagnostic, prognostic, and therapeutic insights in this patient population.

Methods

A comprehensive literature review was conducted using PubMed, Google Scholar, and MEDLINE to identify peer-reviewed English-language studies published between January 2015 and December 2024. Studies were included if they evaluated HRV parameters in individuals with OSA, COPD, or overlap syndrome, explored HRV as a marker of disease severity or progression. A total of 239 studies were identified; after screening, 41 met the inclusion criteria.

Results

The analysis revealed consistent evidence linking reduced HRV with both OSA and COPD severity. HRV alterations were more pronounced in overlap syndrome, reflecting synergistic autonomic dysfunction. HRV showed potential in differentiating disease stages, predicting cardiovascular risk, and evaluating treatment efficacy, particularly for CPAP therapy in OSA. Short-term HRV was particularly sensitive to autonomic changes, while long-term recordings helped track disease progression. Emerging evidence supports the use of HRV derived from wearable technologies as a viable screening tool for health and wellness.

Conclusion

HRV is a valuable, non-invasive tool for assessing autonomic dysfunction in OSA, COPD, and their overlap. It offers significant potential for early diagnosis, disease monitoring, and treatment evaluation. Integrating HRV into clinical practice, could enhance diagnostic efficiency, reduce healthcare burden, and improve outcomes in high-risk respiratory populations. Furthermore, longitudinal studies are warranted to standardise HRV thresholds and validate their use in routine screening protocols.

Sources et attribution

Heart Rate Variability (HRV) in Patients with Sleep Apnea and COPD: A Comprehensive Analysis.

Zabara-Antal A, Crisan-Dabija R, Arcana RI, Melinte OE, Pintilie AL, Grosu-Creanga IA, Zabara ML, Trofor A.

Journal of clinical medicine · 2025-06-30

DOI: 10.3390/jcm14134630 ↗PubMed · 40649003 ↗Europe PMC · Licence indiquée: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée

Sources vérifiées 2026-11-01

Guides pratiques

À lire ensemble

·Article de recherche

Short-term HRV was higher during slow breathing in 962 military men, injured or not

In 962 military men (median age 37.6 years), every short-term heart rate variability (HRV) measure was higher during slow breathing at six breaths a minute than during spontaneous breathing, injured or not; in fast resting breathers RMSSD rose from 15.57 to 21.89 ms. It was one session in a fixed order, so it shows an immediate effect, not lasting benefit.

European Journal of Applied Physiology

Explications approfondiesLire l’étude →
·Méta-analyse d’essais

Cold-water immersion: no strength gain, briefly weaker jumps, soreness relief uncertain

Across 22 randomised trials (375 participants, mostly men), one cold-water immersion after exercise did not change maximal isometric strength (g 0.08, 95% CI −0.11 to 0.26) and was followed by weaker jumping straight afterwards (g −0.68), gone by 24–48 hours. Lower soreness and creatine kinase looked favourable but weakened in sensitivity checks, and certainty was low to very low.

PeerJ

Explications approfondiesLire l’étude →
·Revue des preuves

Cold-water immersion after hard exercise: less soreness, better power, no strength gain

In a meta-analysis of 52 randomised trials, cold-water immersion after high-intensity exercise was followed 24 hours later by lower soreness (SMD −0.89), higher perceived recovery (0.66) and better muscular power (0.22), with no effect on strength. Participants could not be blinded, most were men, and many pooled results rest on few studies with high heterogeneity.

Sports Medicine

Explications approfondiesLire l’étude →
·Méthodes et interprétation

Acute:chronic workload ratio: no evidence it can reduce injury risk, authors argue

The authors argue there is no evidence for using the acute:chronic workload ratio (ACWR) in training-load management or to reduce injury risk: no study has properly estimated a causal effect, and the ratio is statistically inaccurate and ambiguous. This is a methodological critique, not a new data analysis, so it does not show that training load is unrelated to injury.

International Journal of Sports Physiology and Performance

Explications approfondiesLire l’étude →
Récupération →